BioSante Pharmaceuticals, Inc. (BPAX)

[jadite]

Is it possible that all this ambiguity was put in place intentionally to prompt a NO vote?

Just the fact that we just had a 1:6 r/s and now we're heading into another with a yet to be determined ratio?
Being told to vote YES by a firm (Egan-Jones) that has just had a ton of bad press questioning their ethics.
Publication after publication with experts attesting to the efficacy of T for women and yet a low valuation for Libigl?

Is there another example out there where a company did just this? Just like we read one Monday morning that GVAX had been sold; we could read one day that Libigel is sold pre-merger and the CVRs are just a red herring fakeout.
I am waiting until the last day to vote. Too much drama still unfolding. I really want to hear what Susan Davis has to say next week.